Skip to content
Abierto

Award notice, first published as presolicitation

Omeprazole Dr Capsules- NAC Repack

36E79725R0002

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

Awarded

Golden State Medical Supply, Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of December 19, 2024.

Page 5 of 89 Continuation of SF-1449, Block 3: The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation s Section B, Scope of Contract, Section 1.4 Contract Effective Date, Implementation Period, and Ordering Period.

Contract Award/Effective Date:

Implementation Period:

Ordering Period (Base Year):

Offerors shall not enter information into the above fields. Continuation of SF-1449, Blocks 19 through 24: Group 1 (line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b), and Group 2 (line items 1 and 2) represent two separate requirements for purposes of FAR Clause 52.217-9, Option to Extend the Terms of the Contract and Clause 52.233-2 Service of Protest . For the purpose of determining the lowest-priced, technically acceptable offer(s) the Government will evaluate each group separately.

To be considered for award for Group 1, offerors are required to submit prices for Group 1 line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b for the base and all four option years. To be considered for award for Group 2, offerors are required to submit prices for Group 2 line item 1 and 2 for the base and all four option years. Offered prices shall not exceed two decimal places. Award will be made in the aggregate for Group 1 (line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b); and Group 2, (line items 1 and 2).

The Government may award two separate contracts for Group 1 and Group 2, or one contract for both groups. Line items 1 and 4 are unit of use. All unit-of-use packaging identified in the Schedule of Supplies (i.e., 90s) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle.

The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.

Note: NDC is defined as National Drug Code. ANDA is defined as Abbreviated New Drug Application Group 1 (OGAs) Line Item 1 - Omeprazole DR 20mg Capsules, 90 Capsules per Bottle (Unit of Use) NDC

ANDA

Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 238 Bottles Option Year One 238 Bottles Option Year Two 238 Bottles Option Year Three 238 Bottles Option Year Four 238 Bottles Line Item 2 -Omeprazole DR 20mg Capsules, 100 Capsules per Bottle NDC

ANDA

Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 1,633 Bottles Option Year One 1,633 Bottles Option Year Two 1,633 Bottles Option Year Three 1,633 Bottles Option Year Four 1,633 Bottles 3a OR 3b Line Item 3a - Omeprazole DR 20mg Capsules, 500 Capsules per Bottle NDC

ANDA

Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 36,848 Bottles Option Year One 36,848 Bottles Option Year Two 36,848 Bottles Option Year Three 36,848 Bottles Option Year Four 36,848 Bottles OR Line Item 3b - Omeprazole DR 20mg Capsules, 1000 Capsules per Bottle NDC

ANDA

Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 18,424 Bottles Option Year One 18,424 Bottles Option Year Two 18,424 Bottles Option Year Three 18,424 Bottles Option Year Four 18,424 Bottles Line Item 4 - Omeprazole DR 40mg Capsules, 90 Capsules per Bottle (Unit of Use) NDC

ANDA

Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 562 Bottles Option Year One 562 Bottles Option Year Two 562 Bottles Option Year Three 562 Bottles Option Year Four 562 Bottles Line Item 5 -Omeprazole DR 40mg Capsules, 100 Capsules per Bottle NDC

ANDA

Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 592 Bottles Option Year One 592 Bottles Option Year Two 592 Bottles Option Year Three 592 Bottles Option Year Four 592 Bottles 6a OR 6b Line Item 6a - Omeprazole DR 40mg Capsules, 500 Capsules per Bottle NDC

ANDA

Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 11,728 Bottles Option Year One 11,728 Bottles Option Year Two 11,728 Bottles Option Year Three 11,728 Bottles Option Year Four 11,728 Bottles OR Line Item 6b - Omeprazole DR 40mg Capsules, 1000 Capsules per Bottle NDC

ANDA

Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Base Year 5,864 Bottles Option Year One 5,864 Bottles Option Year Two 5,864 Bottles Option Year Three 5,864 Bottles Option Year Four 5,864 Bottles Group 2 (VA) Line Item 1 - Omeprazole DR 20mg Capsules, Bulk NDC

ANDA

Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Drum or PKG Size Base Year 272,800,000 Capsules Option Year One 272,800,000 Capsules Option Year Two 272,800,000 Capsules Option Year Three 272,800,000 Capsules Option Year Four 272,800,000 Capsules Line Item 2 - Omeprazole DR 40mg Capsules, Bulk NDC

ANDA

Schedule of Supplies Quantity Unit Unit Price Amount (Unit Price x Quantity) Drum or PKG Size Base Year 61,000,000 Capsules Option Year One 61,000,000 Capsules Option Year Two 61,000,000 Capsules Option Year Three 61,000,000 Capsules Option Year Four 61,000,000 Capsules ** The minimum package size for Group 2 (bulk) is 1,000 tablet count.

The 1,000 tablet count will be accepted for Group 2 but a larger package size such as 10,000 Tablet drums or larger are desired for the bulk (See Section 1.5 in the Scope of Contract section of this solicitation) For each of the drug strengths listed in Group 2. For the base year only or earlier, if an offeror is not able to provide the drug in larger quantities i.e. 10,000 Tablet drums or larger, VA will accept 1,000 count bottles.

When VA exercises the first option year, the successful offeror awarded the contract under this solicitation must provide in quantities of at 10,000 count drums for each of the strengths. For the purpose of evaluating offers, $0.0314 (VA awarded repackaging fee) per bottle will be added if the bottle is under 10,000 tablet count required to meet the estimated annual requirements.

For example, if 1000 count bottles were proposed for Group 2, item 2 (which has estimated annual requirements of 51,000,000 capsules), $.0314 would be multiplied by 51,000. This figure would be added to the total annual price for price evaluation purposes.

The $0.0314 per bottle represents the repackaging cost to the Government during the base year of contract performance for a contract awarded under this solicitation and will be included in the calculation of the lowest total aggregate price for evaluation of award. ** The estimated annual usage cited above is the Government s total estimated usage for the strength and bottle size/capsule count listed. There is no expressed or implied guarantee that the estimated quantities will be purchased under this contract. Actual quantities purchased may exceed or be less than those represented.

Bulk Product (GROUP 2) must have at least 18 months of dating prior to product expiration on the date of shipment from the contract holder to the Pharmaceutical Repackager.

Price Evaluation note: GROUP 1 will be evaluated based on unit prices (per bottle price) GROUP 2 will be evaluated based on unit prices (per capsule price) + 0.0314 if the tablet count is 1,000 as described above.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
GQLDJJ8AQNN5
CAGE
1HT23
Vendor location
Camarillo, CA
Contract
36E79725D0015
Obligated
$0.00, potential $56,652,371
Actions
8 between January 30, 2025 and May 12, 2026
Competition
Full and Open Competition, 4 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Omeprazole DR Capsules with Golden State Medical Supply, INC. Ordering Period Is 04/01/2025 - 03/31/2026 with Four, ONE-YEAR Option Periods.
Match
award number 36E79725D0015 equals the contract number; same awarding office 36E797 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 28, 2024

    Presolicitation

    Due November 8, 2024 at 3:30 PM EST. SAM.gov, notice 635c2a9dd4a0463c8a12c3bdb3217df1

  2. November 14, 2024

    Solicitation, originally presolicitation

    Due December 3, 2024 at 3:30 PM EST. SAM.gov, notice 2f102a161fe140f399043139930bac06

  3. November 27, 2024

    Solicitation

    Due December 10, 2024 at 3:30 PM EST. SAM.gov, notice a76d22ffb4e849b2acb01ec1656bee57

  4. December 19, 2024

    Solicitation

    Due December 27, 2024 at 3:30 PM EST. SAM.gov, notice 6a88cd3df72149d4ba3ded987076727c

  5. January 30, 2025

    Award notice

    Awarded to Golden State Medical Supply, Inc. Camarillo 93012-8601 for $0. SAM.gov, notice 81f5bf9caa4e4a88b955fda0bf742c1a

Points of contact